Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Cancer Research|November 15, 1993
High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell linesG Emons, O Ortmann, M Becker, et al.Cancer Treatment Reviews|July 3, 2010
Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panelO Ortmann, O Pagani, A Jones, et al.Cancer Research|February 15, 1995
Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinomaG Irmer, C Bürger, R Müller, et al.Geburtshilfe Und Frauenheilkunde|March 5, 2016
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian CancerP Harter, A du Bois, S Mahner, et al.Cancer|October 1, 1996
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study GroupG Emons, O Ortmann, H M Teichert, et al.Journal of Cancer Research and Clinical Oncology|August 9, 2015
Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registryE C Inwald, M Koller, M Klinkhammer-Schalke, et al.Oncology Reports|April 30, 2013
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancersS Seitz, F G Rick, A V Schally, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 11, 2009
Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissueS Schimanski, P J Wild, O Treeck, et al.Human Reproduction (Oxford, England)|November 26, 1999
A simple, inexpensive and effective artificial cycle with exogenous transdermal oestradiol and vaginal progesterone for the transfer of cryopreserved pronucleated human oocytes in women with normal cyclesM Bals-Pratsch, S Al-Hasani, B Schöpper, et al.Archives of Gynecology and Obstetrics|May 10, 2002
Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVFM Ludwig, C Albano, F Olivennes, et al.Pageof 10